BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7854966)

  • 1. Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages.
    de la Fuente M; Delgado M; del Rio M; Garrido E; Leceta J; Hernanz A; Gomariz RP
    Peptides; 1994; 15(7):1157-63. PubMed ID: 7854966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility.
    Garrido E; Delgado M; Martínez C; Gomariz RP; De la Fuente M
    Neuropeptides; 1996 Dec; 30(6):583-95. PubMed ID: 9004257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide (VIP) inhibits substrate adherence capacity of rat peritoneal macrophages by a mechanism that involves cAMP.
    Segura JJ; Guerrero JM; López-Gonzalez MA; Calvo JR
    Cell Adhes Commun; 1993 Dec; 1(3):213-21. PubMed ID: 7521755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat macrophages. Protein kinase C involvement.
    De la Fuente M; Delgado M; del Rio M; Martinez C; Hernanz A; Gomariz RP
    Regul Pept; 1993 Nov; 48(3):345-53. PubMed ID: 8278627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoattractant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritoneal leukocytes.
    Del Rio M; De la Fuente M
    Regul Pept; 1994 Jan; 49(3):185-93. PubMed ID: 8140272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP.
    Delgado M; De la Fuente M; Martínez C; Gomariz RP
    J Neuroimmunol; 1995 Nov; 62(2):137-46. PubMed ID: 7499501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide enhances phorbol myristate acetate-induced chemiluminescence in human lymphocytes.
    Lopez-Gonzalez MA; Guerrero JM; Lucas M
    Life Sci; 1992; 51(23):1803-10. PubMed ID: 1331643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    Turner JT; Bollinger DW; Toews ML
    J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo.
    Delgado M; Ganea D
    J Immunol; 2001 Jul; 167(2):966-75. PubMed ID: 11441105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
    Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
    Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. See-saw signal processing: reciprocal effects of stimulus deprivation on vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate accumulation in rat pinealocytes.
    Chik CL; Ho AK
    Endocrinology; 1991 Feb; 128(2):850-6. PubMed ID: 1846590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of ethanol on the calcium-dependent potentiation of vasoactive intestinal peptide-stimulated cAMP and cGMP accumulation in rat pinealocytes.
    Chik CL; Ho AK
    Biochem Pharmacol; 1991 Sep; 42(8):1601-8. PubMed ID: 1656991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extracellular-signal-regulated kinase1/2 pathways.
    Vlotides G; Zitzmann K; Hengge S; Engelhardt D; Stalla GK; Auernhammer CJ
    Endocrinology; 2004 Feb; 145(2):716-27. PubMed ID: 14605001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions.
    Delgado M; Garrido E; de la Fuente M; Gomariz RP
    Peptides; 1996; 17(7):1097-105. PubMed ID: 8959742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin inhibition of VIP- and isoproterenol-stimulated cyclic AMP production in rat peritoneal macrophages.
    Segura JJ; Guerrero JM; Goberna R; Calvo JR
    Neuropeptides; 1992 Sep; 23(1):39-43. PubMed ID: 1357581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of murine lymphocyte functions by sulfated cholecystokinin octapeptide.
    De la Fuente M; Carrasco M; Del Rio M; Hernanz A
    Neuropeptides; 1998 Jun; 32(3):225-33. PubMed ID: 10189056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide.
    Johnston JA; Taub DD; Lloyd AR; Conlon K; Oppenheim JJ; Kevlin DJ
    J Immunol; 1994 Aug; 153(4):1762-8. PubMed ID: 7519212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between cellular signaling pathways activated by substance P and vasoactive intestinal peptide in rat lactotroph-enriched pituitary cell cultures.
    Mau SE; Saermark T; Vilhardt H
    Endocrinology; 1997 Apr; 138(4):1704-11. PubMed ID: 9075734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis.
    Schratzberger P; Geiseler A; Dunzendorfer S; Reinisch N; Kähler CM; Wiedermann CJ
    J Neuroimmunol; 1998 Jul; 87(1-2):73-81. PubMed ID: 9670847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.